Diabetes and Alzheimer's Disease.
作者信息
Bloomgarden Zachary
机构信息
Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
出版信息
J Diabetes. 2025 May;17(5):e70103. doi: 10.1111/1753-0407.70103.
Abstract
摘要
相似文献
1
Diabetes and Alzheimer's Disease.糖尿病与阿尔茨海默病
J Diabetes. 2025 May;17(5):e70103. doi: 10.1111/1753-0407.70103.
2
Is Alzheimer's disease a type 3 diabetes? A review.阿尔茨海默病是 3 型糖尿病吗？一篇综述。
Cent Eur J Public Health. 2022 Sep;30(3):139-143. doi: 10.21101/cejph.a7238.
3
Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.线粒体和氧化应激作为阿尔茨海默病和糖尿病之间的联系。
Int J Mol Sci. 2023 Sep 22;24(19):14450. doi: 10.3390/ijms241914450.
4
Links between Alzheimer's disease and diabetes.阿尔茨海默病与糖尿病之间的联系。
Timely Top Med Cardiovasc Dis. 2006 Oct 1;10:E24.
5
Links between Alzheimer's disease and diabetes.阿尔茨海默病与糖尿病之间的联系。
Drugs Today (Barc). 2006 Jul;42(7):481-9. doi: 10.1358/dot.2006.42.7.973588.
6
Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis.基质金属蛋白酶 14 调节糖尿病与阿尔茨海默病的相互作用：一项荟萃分析。
Neurol Sci. 2018 Feb;39(2):267-274. doi: 10.1007/s10072-017-3166-4. Epub 2017 Nov 4.
7
Diabetes, Alzheimer's disease and apolipoprotein genotype.糖尿病、阿尔茨海默病与载脂蛋白基因型
Exp Gerontol. 2003 Sep;38(9):941-6. doi: 10.1016/s0531-5565(03)00153-0.
8
Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease.甘丙肽水平升高可能预示2型糖尿病患者发生阿尔茨海默病的风险。
Mech Ageing Dev. 2015 Sep;150:20-6. doi: 10.1016/j.mad.2015.08.001. Epub 2015 Aug 4.
9
Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.全球视角下的阿尔茨海默病与糖尿病：威胁、风险与治疗——阿尔茨海默病与糖尿病。
Curr Alzheimer Res. 2018;15(14):1277-1282. doi: 10.2174/1567205015666180925110222.
10
Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort.糖尿病作为阿尔茨海默病功能障碍和衰退的调节剂。REAL.FR 队列。
Diabet Med. 2012 Apr;29(4):541-8. doi: 10.1111/j.1464-5491.2011.03445.x.
本文引用的文献
1
A systematic analysis for disease burden, risk factors, and trend projection of Alzheimer's disease and other dementias in China and globally.中国及全球阿尔茨海默病和其他痴呆症的疾病负担、风险因素及趋势预测的系统分析。
PLoS One. 2025 May 7;20(5):e0322574. doi: 10.1371/journal.pone.0322574. eCollection 2025.
2
Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis.具有心脏保护作用的降糖药物与痴呆风险：一项系统评价和荟萃分析
JAMA Neurol. 2025 May 1;82(5):450-460. doi: 10.1001/jamaneurol.2025.0360.
3
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias.用于2型糖尿病及阿尔茨海默病和相关痴呆症的胰高糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂药物
JAMA Neurol. 2025 May 1;82(5):439-449. doi: 10.1001/jamaneurol.2025.0353.
4
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: the need for rigor.强化生活方式改变对阿尔茨海默病所致轻度认知障碍或早期痴呆进展的影响：严谨性的必要性。
Alzheimers Res Ther. 2025 Feb 1;17(1):32. doi: 10.1186/s13195-024-01621-6.
5
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.EVOKE和EVOKE+：两项大型、双盲、安慰剂对照的3期研究设计，评估司美格鲁肽在早期有症状阿尔茨海默病中的疗效、安全性和耐受性。
Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi: 10.1186/s13195-024-01666-7.
6
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.基于生活方式的阿尔茨海默病管理干预措施的系统评价：来自随机对照试验的见解。
J Alzheimers Dis. 2024 Dec;102(4):943-966. doi: 10.1177/13872877241292829. Epub 2024 Nov 25.
7
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.40-69 岁 2 型糖尿病成人中钠-葡萄糖共转运蛋白 2 抑制剂与二肽基肽酶-4 抑制剂起始治疗后痴呆风险的比较：基于人群的队列研究。
BMJ. 2024 Aug 28;386:e079475. doi: 10.1136/bmj-2024-079475.
8
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship.探索交叉点：糖尿病与阿尔茨海默病的交织关系。
Ageing Res Rev. 2024 Sep;100:102415. doi: 10.1016/j.arr.2024.102415. Epub 2024 Jul 14.
9
Association of sulfonylureas with the risk of dementia: A population-based cohort study.磺脲类药物与痴呆风险的关联：一项基于人群的队列研究。
J Am Geriatr Soc. 2023 Oct;71(10):3059-3070. doi: 10.1111/jgs.18397. Epub 2023 May 22.
10
Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 Diabetes.血糖控制数十年与 2 型糖尿病患者的痴呆风险。
JAMA Neurol. 2023 Jun 1;80(6):597-604. doi: 10.1001/jamaneurol.2023.0697.
Zotero 插件